GS vs NMR
Goldman Sachs and Nomura Holdings, Inc., both Financial Services
Goldman Sachs is the larger company at $323B against $26B. Over the past year GS returned +46% against +45% for NMR. Ryufin's sector-relative Smart Score puts NMR ahead, 8/10 against 5/10.
| Figure | GS | NMR |
|---|---|---|
| Last close | $1041 | $10.05 |
| Market cap | $323B | $26B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 16.1 | n/a |
| Dividend yield | 1.3% | n/a |
| 1-year return | +46% | +45% |
| 5-year return | +213% | +123% |
| Ryufin Smart Scoresector-relative, 1–10 | 5/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Goldman Sachs
Revenue of $20B in Q2 2026, net income $6.6B.
Nomura Holdings, Inc.
Revenue of $2.4T in H2 2026, net income $165B.
Open these two in the interactive comparison to add more names, change the period or read the correlation.